The endocannabinoid system: potential for reducing cardiometabolic risk
- PMID: 19373218
- PMCID: PMC2905146
- DOI: 10.1038/oby.2009.107
The endocannabinoid system: potential for reducing cardiometabolic risk
Figures


References
-
- Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health. National Institutes of Health. Obes Res. 1998;6(Suppl 2):51S–209S. - PubMed
-
- Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621–628. - PubMed
-
- Rosenbaum M, Vandenborne K, Goldsmith R, et al. Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects. Am J Physiol Regul Integr Comp Physiol. 2003;285:R183–R192. - PubMed
-
- Gong Y, Ishida-Takahashi R, Villanueva EC, et al. The long form of the leptin receptor regulates STAT5 and ribosomal protein S6 via alternate mechanisms. J Biol Chem. 2007;282:31019–31027. - PubMed
-
- Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443:289–295. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical